(19)
(11) EP 4 581 142 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23764301.0

(22) Date of filing: 30.08.2023
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/141; C12N 2310/3519; C12N 2320/32
(86) International application number:
PCT/EP2023/073808
(87) International publication number:
WO 2024/047115 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2022 EP 22193672

(71) Applicant: Leibniz-Institut für Immuntherapie (LIT)
93053 Regensburg (DE)

(72) Inventors:
  • GATTINONI, Luca
    93059 Regensburg (DE)
  • SLAVKOVIC-LUKIC, Dragana
    93053 Regensburg (DE)
  • LACEY, Neal
    Los Angeles, California CA90016 (US)
  • JI, Yun
    Germantown, Maryland MD20874 (US)

(74) Representative: Hutter, Bernd 
b-hip Gernlindener Weg 21
82256 Fürstenfeldbruck
82256 Fürstenfeldbruck (DE)

   


(54) THERAPEUTIC USE OF THE MIR155 SNP RS377265631